Working… Menu
Trial record 2 of 4 for:    MS1819

A Phase IIa Study With Escalating Dose of MS1819-SD

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT03481803
Recruitment Status : Completed
First Posted : March 29, 2018
Last Update Posted : September 28, 2018
Information provided by (Responsible Party):
AzurRx SAS

No Study Results Posted on for this Study
Recruitment Status : Completed
Actual Primary Completion Date : June 29, 2018
Actual Study Completion Date : June 29, 2018